Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cytogenet Genome Res ; 119(1-2): 9-14, 2007.
Article in English | MEDLINE | ID: mdl-18160775

ABSTRACT

We report on the molecular basis of the rare, folate-sensitive fragile site FRA11A in chromosome band 11q13 in a family with cytogenetic expression. Five individuals express the fragile site and one was mentally retarded. Expansion of a polymorphic CGG-repeat located at the 5' end of the C11orf80 gene causes FRA11A. The CGG-repeat elongation coincides with hypermethylation of the adjacent CpG island and subsequent transcriptional silencing of the C11orf80 gene. This gene has no homology with known genes. A relationship between cytogenetic expression of the fragile site and the mental handicap seems unlikely, as FRA11A was found in a mentally retarded patient as well as in phenotypically normal carriers from the same family. However, incomplete penetrance cannot be entirely excluded.


Subject(s)
Chromosome Fragile Sites/drug effects , Chromosome Fragile Sites/genetics , Chromosomes, Human, Pair 11/genetics , Folic Acid/pharmacology , Computational Biology , Female , Gene Expression Regulation/genetics , Humans , In Situ Hybridization, Fluorescence , Male , Pedigree , Phenotype
2.
Clin Genet ; 69(1): 58-64, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16451137

ABSTRACT

Subtelomeric rearrangements are believed to be responsible for 5-7% of idiopathic mental retardation cases. Due to the relative complexity and high cost of the screening methods used till now, only preselected patient populations including mostly the more severely affected cases have been screened. Recently, multiplex ligation-dependent probe amplification (MLPA) has been adapted for use in subtelomeric screening, and we have incorporated this technique into routine diagnostics of our laboratory. Since the evaluation of MLPA as a screening method, we tested 275 unselected patients with idiopathic mental retardation and detected 12 possible subtelomeric aberrations: a der(11)t(11;20)(qter;qter), a 19pter duplication, a der(18)t(18;10)(qter; pter), a 15qter deletion, a 8pter deletion, a 6qter deletion, a der(X)t(X;1)(pter;qter), a der(X)t(X;3)(pter;pter), a 5qter duplication, a 3pter deletion, and two 3qter duplications. The patients can be subdivided into two groups: the first containing de novo rearrangements that are likely related to the clinical presentation of the patient and the second including aberrations also present in one of the parents that may or may not be causative of the mental retardation. In our patient cohort, five (1.8%) subtelomeric rearrangements were de novo, three (1.1%) rearrangements were familial and suggestively disease causing, and four (1.5%) were possible polymorphisms. This high frequency of subtelomeric abnormalities detected in an unselected population warrants further investigation about the feasibility of routine screening for subtelomeric aberrations in mentally retarded patients.


Subject(s)
Chromosome Aberrations , Genetic Testing/methods , Intellectual Disability/genetics , Ligase Chain Reaction/methods , Telomere , Base Sequence , Child , Child, Preschool , DNA Probes , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Karyotyping , Male , Molecular Sequence Data
SELECTION OF CITATIONS
SEARCH DETAIL
...